PRESS AND MEDIA

Register here to receive our news releases.

MEDIA SUPPORT

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Principal manager
Media relations and corporate communication

Email: Kathy Robertson

Tel: (351) 211 21 02 00/32

Mobile. (351) 935 994 027

News

Displaying 1 - 20 of 36

EU drugs agency announces Scientific Committee line-up for next three years

On 5 December, the EMCDDA Management Board appointed 15 high-level scientists to serve on the agency’s Scientific Committee for the period 2014–16. The selection followed a call for expressions of interest in...

EMCDDA launches first four studies in a new series targeting policymakers and specialists

The EU drugs agency (EMCDDA) publishes today the first four studies in its brand new series of ‘EMCDDA Papers’. Primarily targeting policymakers and specialists, the papers are designed as brief and timely...

EMCDDA launches new toolkit for monitoring infectious diseases among people who inject drugs

Ahead of World AIDS Day on 1 December, the EU drugs agency (EMCDDA) has released today a new toolkit offering countries the latest guidance on monitoring infectious diseases, such as HIV/AIDS and...

EMCDDA hosts workshop on evidence sharing to prevent and reduce harm related to addiction

Sharing evidence to help prevent and reduce harm related to addiction is the focus of a workshop hosted by the EU drugs agency (EMCDDA) in Lisbon this week. The two-day event, opening...

Europe takes decisive step forward in monitoring drug supply

A set of Council conclusions on improving the monitoring of drug supply in the European Union was adopted by the Economic and Financial Affairs Council meeting in Brussels today (1). While much...

2013 EMCDDA scientific paper award applauds excellence in drug-related research

The four winners of the 2013 EMCDDA scientific paper award will be honoured in Lisbon this week at the third annual award ceremony hosted by the EU agency (1). The winners —...

CICAD–OAS Executive Secretary, Ambassador Paul E. Simons, visits EMCDDA to discuss cooperation and perspectives for work programme 2014–18

Ambassador Paul E. Simons, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD) of the Organization of American States (OAS) visits the EMCDDA today to discuss with the agency’s Director Wolfgang...

Wound botulism among people who inject heroin in Norway – joint ECDC/EMCDDA rapid risk assessment

As of 28 October 2013, six cases of wound botulism have been reported in Norway among people who had injected heroin. Two cases have been confirmed through mice inoculation and four are...

EMCDDA publications recognised by the American Library Association

Three of the EMCDDA’s publications have recently been recognised among the ‘notable government documents 2012’ by the American Library Association (ALA). The three publications are: the EU drug markets report: a strategic...

EMCDDA: 20 years

It is 20 years today since the EMCDDA’s founding regulation, Council Regulation (EEC) Nº 302/93, came into effect. On 29 October 1993, the Heads of State decided that the seat of the...

Reitox Academy: Preventing and controlling infectious diseases among people who inject drugs

Preventing and controlling infectious diseases among people who inject drugs is the focus of the latest EMCDDA Reitox Academy opening today in Sarajevo (Bosnia and Herzegovina). The two-day event gathers over 20...

EMCDDA Director opens workshop showcasing Croatia’s national drug monitoring system

EMCDDA Director Wolfgang Götz will be opening a workshop today in Zadar, Croatia, in his first official visit to the country since its accession to the EU in July 2013. The two-day...

EMCDDA supports national drug observatories via training on contemporary approaches to drug monitoring

‘Analysing, interpreting and disseminating drug-related data to facilitate decision-making’ will be the focus of an innovative training course hosted by the EU drugs agency (EMCDDA) this week in Lisbon. Opening today and...

New-style EMCDDA expert meetings promote integrated approach to monitoring

The first EMCDDA week on ‘Measuring, understanding and responding to drug problems in Europe’ opens today in Lisbon, gathering experts from across the European Union, as well as the Russian Federation, South...

EMCDDA welcomes European Commission call for stronger EU action on new drugs

The EU drugs agency (EMCDDA) welcomes the European Commission's proposal today to strengthen the EU’s response to new psychoactive substances (‘new drugs’)(1). The proposal follows an unprecedented rise in the number of...

Experts to examine latest scientific research in the field of new drugs

Novel (or new) psychoactive substances (NPS) are an ever-increasing group of synthetic, semi-synthetic or natural compounds, often advertised and sold as ‘legal’ alternatives to illicit drugs. Often misrepresented as ‘safe’ for recreational...

European Parliament LIBE Committee members on fact-finding visit to EMCDDA

Members of the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) will visit the EU drugs agency (EMCDDA) on 18 and 19 July where they will meet Director Wolfgang...

Speech by Wolfgang Götz, EMCDDA Director at the Third international multi-disciplinary forum on new drugs

It is a great pleasure for me to welcome you to the Third international multidisciplinary forum on new drugs. I am really glad to see such an impressive audience of European and...

New EMCDDA report reveals how a better understanding of the science of ‘addiction’ can improve our response to drug problems

Addiction is a global issue that costs many millions of lives each year and causes untold suffering. In a new report, released today to mark International day against drug abuse and illicit...

Speech by Wolfgang Götz, EMCDDA Director

Dear Ambassadors and members of the Lisbon diplomatic community Dear Representatives of the Portuguese authorities Ladies and gentlemen, dear colleagues and friends It is my great pleasure to welcome you today, together...